Skip to main content

Jeong Yoon-sook

Sungkyunkwan University · Medicine

About the Lab

Professor Jeong Yoon-sook's research lab specializes in gastrointestinal and inflammatory diseases, with a strong focus on inflammatory bowel disease (IBD), Helicobacter pylori infection, and rare gastrointestinal conditions such as Behçet’s disease. The lab investigates novel therapeutic strategies, including vonoprazan-based eradication therapy for H. pylori and biosimilar infliximab (CT-P13) for IBD, emphasizing real-world efficacy and long-term outcomes. It also explores cancer risk in IBD patients and endoscopic management of small colorectal polyps, combining clinical research with translational insights for improved patient care.

inflammatory bowel diseaseHelicobacter pyloribiosimilarsendoscopic resectionBehçet’s disease

Research Overview

Papers
226
Total Citations
4,144
Papers (5y)
27
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
27total
2022
2023
2024
2025
2026
Citations per year (5y)
239total
20222023202420252026

Selected Papers

15
1
Review|177 citations·2017
Systematic review with meta‐analysis: the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication
Yoon Suk Jung, E. H. Kim, Chan Hyuk Park
SJR Q1Alimentary Pharmacology & TherapeuticsOA

BACKGROUND: In order to increase eradication rates, vonoprazan, a novel potassium-competitive acid blocker, has been used in Helicobacter pylori eradication therapy. AIM: To summarise the results of the efficacy of vonoprazan-based triple therapy, helping clinicians to better understand the benefit of vonoprazan in the treatment of H. pylori infection. METHODS: We conducted a systematic literature search on MEDLINE, EMBASE, and the Cochrane Library using the primary keywords "vonoprazan," "takec

SurgeryMedicine
2
Article|176 citations·2015
Efficacy and safety of CT‐P13, a biosimilar of infliximab, in patients with inflammatory bowel disease: A retrospective multicenter study
Yoon Suk Jung, Dong Il Park, Young Ho Kim, Ji Hyun Lee, Pyoung Ju Seo, Jae Hee Cheon, Hyoun Woo Kang, Ji Won Kim
SJR Q1Journal of Gastroenterology and Hepatology

BACKGROUND AND AIM: A biosimilar of infliximab, CT-P13 (Remsima®) has the potential to reduce treatment costs and enhance access to biological therapy for inflammatory bowel disease (IBD) patients. However, long-term clinical data on its use for IBD treatment are currently sparse. We aimed to investigate the long-term efficacy and safety of CT-P13 therapy in a large, real-life IBD cohort. METHODS: A total of 368 IBD patients (227 with Crohn's disease [CD] and 141 with ulcerative colitis [UC]) tr

ImmunologyImmunology and Microbiology
3
Article|117 citations·2017
Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study
Yoon Suk Jung, Minkyung Han, Sohee Park, Won Ho Kim, Jae Hee Cheon
SJR Q1Journal of Crohn s and ColitisOA

BACKGROUND AND AIMS: The association between inflammatory bowel disease [IBD] and cancer remains poorly defined in Asian populations. Therefore, we conducted a nationwide population-based study to determine the cancer risk in Korean patients with IBD. METHODS: Using the National Health Insurance claims data, we collected data on patients diagnosed with IBD (5595 Crohn's disease [CD] and 10 049 ulcerative colitis [UC]) from 2011 to 2014. Standardized incidence ratios [SIRs] of overall and site-sp

GeneticsBiochemistry, Genetics and Molecular Biology
4
Article|87 citations·2010
Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcetʼs disease
Yoon Suk Jung, Jin Young Yoon, Jin Ha Lee, Soung Min Jeon, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
SJR Q1Inflammatory Bowel DiseasesOA

BACKGROUND: To date there have been few studies regarding the efficacy of surgical treatment and related prognostic factors following intestinal resection in patients with intestinal Behcet's disease (BD). Here we investigated the long-term clinical outcomes and related prognostic factors after surgical treatment for intestinal BD. METHODS: We reviewed the medical records of 72 patients with intestinal BD who underwent surgery between March 1986 and May 2010. Prognostic factors were identified b

OphthalmologyMedicine
5
Article|78 citations·2018
Prevalence of and Risk Factors for Colorectal Neoplasia in Asymptomatic Young Adults (20–39 Years Old)
Nam Hee Kim, Yoon Suk Jung, Hyo‐Joon Yang, Soo‐Kyung Park, Jung Ho Park, Dong Il Park, Chong Il Sohn
SJR Q1Clinical Gastroenterology and Hepatology
OncologyMedicine
6
Article|76 citations·2014
Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years
Yoon Suk Jung, Seungho Ryu, Yoosoo Chang, Kyung Eun Yun, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Dong Il Park
SJR Q1Gastrointestinal Endoscopy
OncologyMedicine
7
Article|65 citations·2017
Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011–2014: A Nationwide Population-Based Study
Yoon Suk Jung, Minkyung Han, Won Ho Kim, Sohee Park, Jae Hee Cheon
SJR Q2Digestive Diseases and SciencesOA
GeneticsBiochemistry, Genetics and Molecular Biology
8
Article|63 citations·2013
Complete biopsy resection of diminutive polyps
Yoon Suk Jung, Jung Woo Park, Hong Kwan Kim, Yong‐Yeon Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Gon Kim, Jin Hee Sohn, Dong Il Park
SJR Q1Endoscopy

In this small study approximately 90 % of all diminutive polyps and 100% of 1-3-mm adenomatous polyps were completely resected using CBP and chromoendoscopy. CBP appears to be adequate for the resection of the majority of diminutive polyps, especially small sized adenomas (≤ 3 mm) if no residual tissue is visible by chromoendoscopy.

Pulmonary and Respiratory MedicineMedicine
9
Article|63 citations·2012
Clinical Course of Intestinal Behcet’s Disease During the First Five Years
Yoon Suk Jung, Jae Hee Cheon, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
SJR Q2Digestive Diseases and SciencesOA
OphthalmologyMedicine
10
Article|61 citations·2012
Long-Term Clinical Outcomes and Factors Predictive of Relapse After 5-Aminosalicylate or Sulfasalazine Therapy in Patients With Intestinal Behcet Disease
Yoon Suk Jung, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon
SJR Q2Journal of Clinical Gastroenterology

This study has shown that 5-ASA/sulfasalazine therapy has a positive effect in maintaining remission in patients with intestinal BD. However, a younger age (<35 y), higher C-reactive protein level (≥1.5 mg/dL), and a higher disease activity index for intestinal Behcet disease score (≥60) were associated with a poor response to 5-ASA/sulfasalazine therapy, making careful observation and intensive treatment necessary in these risk groups.

OphthalmologyMedicine
11
Article|61 citations·2014
Risk Factors Associated with Rectal Neuroendocrine Tumors: A Cross-Sectional Study
Yoon Suk Jung, Kyung Eun Yun, Yoosoo Chang, Seungho Ryu, Jung Ho Park, Hong Joo Kim, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Dong Il Park
SJR Q1Cancer Epidemiology Biomarkers & PreventionOA

BACKGROUND: The incidence of rectal neuroendocrine tumors (NET) has been increasing since the implementation of the screening colonoscopy. However, very little is known about risk factors associated with rectal NETs. We examined the prevalence of and the risk factors for rectal NETs in a Korean population. METHODS: A cross-sectional study was performed on 62,171 Koreans who underwent screening colonoscopy. The clinical characteristics and serum biochemical parameters of subjects with rectal NET

EpidemiologyMedicine
12
Article|56 citations·2018
Physical Inactivity and Unhealthy Metabolic Status Are Associated with Decreased Natural Killer Cell Activity
Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Jae Myun Lee, Tae Il Kim
SJR Q2Yonsei Medical JournalOA

Physical inactivity and metabolic abnormalities are associated with reduced NK cell activity. Immune systems may become altered depending on physical activity and metabolic status.

PhysiologyMedicine
13
Article|56 citations·2012
Long-term Clinical Outcomes of Crohnʼs Disease and Intestinal Behcetʼs Disease
Yoon Suk Jung, Jae Hee Cheon, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim
SJR Q1Inflammatory Bowel DiseasesOA

There were no significant differences in the long-term clinical outcomes and postoperative prognoses between CD and intestinal BD, although CD patients required corticosteroid or immunosuppressant therapy more often than intestinal BD patients.

GeneticsBiochemistry, Genetics and Molecular Biology
14
Article|54 citations·2011
Surface modification of pancreatic islets using heparin-DOPA conjugate and anti-CD154 mAb for the prolonged survival of intrahepatic transplanted islets in a xenograft model
Yoon Suk Jung, Jee‐Heon Jeong, Simmyung Yook, Bok-Hyeon Im, Jinwon Seo, Sung Woo Hong, Jun‐Beom Park, Victor C. Yang, Dong Yun Lee, Youngro Byun
SJR Q1Biomaterials
SurgeryMedicine
15
Review|53 citations·2016
Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
SJR Q1Journal of Gastroenterology and Hepatology

Abstract Background and Aim Although it is known that metformin can reduce risk of colorectal cancer, it is unclear whether it protects against colorectal adenoma. Methods This study conducted a systematic literature search on MEDLINE, EMBASE, and the Cochrane Library using the primary keywords “colorectal,” “colon,” “rectal,” “rectum,” “adenoma,” “polyp,” “neoplasia,” “neoplasm,” “metformin,” and “diabetes.” Studies were included if they evaluated the association between metformin use and color

Molecular BiologyBiochemistry, Genetics and Molecular Biology

Research Areas

OncologyGeneticsSurgeryPulmonary and Respiratory MedicineOphthalmologyEpidemiology

Dive deeper into Jeong Yoon-sook's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.